Subependymal Giant Cell Astrocytoma — Trials

Subependymal Giant Cell Astrocytoma — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02654340	Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)(TuScCom)	terminated	—	20	CENTOGENE GmbH RostockINDUSTRY	8	Feb 10, 2023	clinicaltrials
NCT02175745	18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas	terminated	N/A	2	Erik MittraOTHER	1	Mar 20, 2017	clinicaltrials
NCT01088763	Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia	terminated	Phase 1	129	National Cancer Institute (NCI)NIH	2	Nov 5, 2014	clinicaltrials

Data updated 23 days agoSource updated Feb 10, 2023source: clinicaltrials